Pricing Log in Create free account

Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) vs SeaStar Medical Holding Corporation (ICU)

Chemomab Therapeutics Ltd. Sponsored ADR and SeaStar Medical Holding Corporation are both Biotechnology companies. SeaStar Medical Holding Corporation is the larger, with a market value of $10.2M against $9.1M — 1.1× the size. Chemomab Therapeutics Ltd. Sponsored ADR has the higher net margin (0.00% vs −795.5%) and the lower return on invested capital (−247.4% vs 0.00%). Across the 13 metrics below, Chemomab Therapeutics Ltd. Sponsored ADR leads on 8 and SeaStar Medical Holding Corporation on 5.

Valuation

Metric CMMB ICU Biotechnology median
P/E n/m n/m 10.26
P/S n/m 4.53 9.18
P/B 1.17 1.81 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 1.96 8.98
Earnings yield (62.99%) (205.79%) (34.89%)
Free cash flow yield (358.23%) (176.47%) (24.52%)

Profitability

Metric CMMB ICU Biotechnology median
Gross margin 0.00% 92.64% 65.16%
Operating margin 0.00% (816.75%) 0.00%
Net margin 0.00% (795.50%) 0.00%
Free cash flow margin 0.00% (799.36%) 0.00%
Return on equity (82.17%) (356.87%) (50.12%)
Return on assets (70.70%) (160.02%) (45.60%)
Return on invested capital (247.40%) 0.00% 0.00%

Growth

Metric CMMB ICU Biotechnology median
Revenue growth (TTM) — 123.63% 6.26%
EPS growth (last fiscal year) 53.65% 91.16% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMMB ICU Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.41 1.89 4.89
Net debt to EBITDA 1.09 0.99 1.01

Dividend

Metric CMMB ICU Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CMMB ICU Biotechnology median
Market cap 9.06m 10.20m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack